F11R and breast carcinoma: Naik et al. [18] initially reported that JAM-A expression is negatively associated with breast cancer aggressiveness and metastasis in 12 tumors and the corresponding non-neoplastic tissue, as well as 50 malignant and corresponding metastatic lymph node samples.